Genescience Pharmaceuticals Co., Ltd.
rhG-CSF (rDNA origin) injection / Scimax®Filgrastim
• The world's rhG-CSF with 174 amino acid residues made by patented E.coli secretion technology (patent # ZL 98 1 03011.4)
• Biological potency higher than that of Neupogen (Filgrastim by Amgen)
• Leading G-CSF brand in China; Launchen in China in 1998
• Eight years of good safety history on the market with no unexpected side effects
Clinical Indications:
• Neutropenia induced by chemotherapy and bone marrow transplantation
Contact Details
|
Genescience Pharmaceuticals Co., Ltd. No.72 Tianhe Rd, High & New Technology Development Zone Tel: 86-431-85195060 Fax: 86-431-85186819 Email: export@gensci-china.com
Homepage Address http://www.gensci-china.com |
Key Contact: Mr. Frank Liu |
